StockTipsArenaBeta

BUY Ajanta Pharma Limited — Pradeep Haldar, PHD Capital

BUYAjanta Pharma Limited

byPradeep Haldar, PHD CapitalHorizon: 1 year31 Jul 2026via Business Today

Entry₹3,436.2Inferred
Target₹3,750
Total upside +9.13%
Stop loss₹3,150-8.33% risk
CMP₹3,486.3Just now
Active+1.46%+7.56%upside left 11 mo left
Follow Pradeep Haldar for new callsGet alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 2 other Long-term calls on AJANTPHARMSee 55 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 9:39 am IST
8 supporting2 neutral4 opposing
Supports the BUY call (8)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·7 Sept · yesterday

Ajanta Pharma Shares Rise 2% as Q1 Profit Reaches Rs 334 Crore

NewsGoogle News·14 Aug · 3w ago

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·10 Aug · 4w ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·7 Jul · 2mo ago

Neutral / worth noting (2)

Nothing found in this tip’s window yet.

Weighs against the BUY call (4)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.